Because higher variation in BCL2 expression could be explained by the presence of early T-cell precursor (ETP)-ALL, we analyzed three patient cohorts (in which patients were labeled as ETP- or non-ETP-ALL) with the ETP-ALL samples removed. Here, BCL2 is linked to acute lymphoblastic leukemia.